LGALS4 and neoplasm: In this study, we investigated the pathophysiological role of extracellular gal 4 in PDAC, describe for the first time the pivotal role of gal 4 in PDAC tumor-mediated immune suppression, and highlight extracellular gal 4 as a promising target for future drug development.